5月8日，泰达生物（08189）发布公告，完成了根据一般授权配售新股的事项。此次配售共涉及1.04亿股，配售价格为每股0.375港元。

根据公告，配售事项于2025年5月8日完成，配售股份相当于配售事项完成后已发行股本的约4.85%。公告中提到，配售的承配人均为独立于公司的第三方投资者。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.